Standard Biotools Inc. (LAB): Cash & Equivalents
$120.86M
As of 2025-12-31
$270.03M
As of 2026-06-30
+14.1%
3-year compound annual growth
+12.0%
5-year compound annual growth
+15.3%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $120.86M | -27.5% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $166.73M | +222.5% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $51.70M | -36.4% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $81.31M | +185.8% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $28.45M | -58.5% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $68.52M | +216.3% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $21.66M | -77.3% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $95.40M | +64.3% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $58.06M | +65.7% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $35.05M | +20.4% | 2019-03-18, Balance as of period end |
| 2015-12-31 | $29.12M | -13.6% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $33.71M | -4.4% | 2017-03-03, Balance as of period end |
| 2013-12-31 | $35.26M | -39.9% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $58.65M | +332.7% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $13.55M | +136.8% | 2014-03-12, Balance as of period end |
| 2010-12-31 | $5.72M | -60.8% | 2013-03-12, Balance as of period end |
| 2009-12-31 | $14.60M | n/a | 2012-03-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Standard Biotools Inc. (LAB) | 2025-12-31 | $120.86M | -27.5% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $41.32M | -18.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $246.96M | +124.5% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $122.52M | +29.2% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $230.91M | -2.6% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $261.34M | +4.2% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $25.94M | +73.7% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $154.97M | -0.3% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $12.67M | -66.7% |
Compare LAB, SPRY, NRIX, CYTK side by side · Screen every company in Pharmaceutical Preparations ↗